Ascletis doses healthy subjects in Phase I trial of oral Covid-19 tablets
Another 12 subjects will be randomised and given two single 800mg doses for evaluating the food effect on ASC10 tablets’ PK.
MEDELPHARM WP
Prothione capsules reduce Covid-19 viral load in Phase II trial
Vaxart begins dosing in Phase II trial of oral tablet vaccine for Covid-19
Gilead reports favourable data from trial of Descovy tablets
Cara Therapeutics begins Phase Ia/Ib trial of tablet formulation of oral pain drug CR845
Pfizer Phase 4 Lyrica capsules CV Study meets primary endpoint
Lannett Loxapine capsules get FDA approval
